Clinical usefulness of AGEs as a biomarker for the attenuation of NASH.
Department of Internal Medicine, Gulhane School of Medicine, Ankara, Turkey, .Journal of Gastroenterology (impact factor: 4.16). 03/2010; 45(7):779-80; author reply 781. DOI:10.1007/s00535-010-0229-1 pp.779-80; author reply 781
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.